BCM
CELG

Bluefin Capital Management’s Celgene Corp CELG Stock Holding History

Bluefin Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,223
Closed -$1.61M – 815
2019
Q3 		$1.61M Sell
16,223
-1,566
-9% -$149K 0.23% 78
2019
Q2 		$1.64M Sell
17,789
-50,911
-74% -$4.83M 0.23% 71
2019
Q1 		$6.48M Buy
+68,700
New +$6.01M 0.94% 21
2017
Q4 		– Sell
-2,053
Closed -$299K – 698
2017
Q3 		$299K Sell
2,053
-1,908
-48% -$260K 0.04% 268
2017
Q2 		$514K Buy
+3,961
New +$485K 0.06% 231
2016
Q3 		– Sell
-5,232
Closed -$516K – 658
2016
Q2 		$516K Buy
+5,232
New +$541K 0.05% 201
2015
Q3 		– Sell
-4,369
Closed -$506K – 664
2015
Q2 		$506K Buy
+4,369
New +$499K 0.03% 298

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Bluefin Capital Management's CELG Position: Q4 2019 in Review

Bluefin Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,223 shares — an estimated $1.61M sold.

Bluefin Capital Management first reported a position in CELG in Q2 2015 and held it in 7 quarters. The position peaked at $6.48M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bluefin Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bluefin Capital Management sold 16,223 Celgene Corp shares in Q4 2019, an estimated $1.61M.
  • Bluefin Capital Management first reported a position in Celgene Corp in Q2 2015 and held it in 7 quarters.
  • Bluefin Capital Management's Celgene Corp position peaked at $6.48M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bluefin Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.